Dr. Lieberman is a distinguished clinician-scientist and a dynamic clinical program builder. Under his leadership, the Department of Orthopaedic Surgery has grown in prestige and reach, and garnered a national reputation for excellence in clinical care and as a top training site for future orthopaedic surgeons.
Jay R. Lieberman, MD, is an internationally recognized expert in hip and knee replacement and treatment of osteonecrosis (bone death) of the hip and knee. He is a pioneer in the field of musculoskeletal gene therapy to promote bone repair. He has served as professor and chair of the Department of Orthopaedic Surgery at the Keck School of Medicine of USC and director of the Institute of Orthopaedics at the Keck Medical Center of USC since 2012. Previously, he was president of the USC Care Medical Group.
Jay R. Lieberman, MD
Professor and Chair, Department of Orthopaedic Surgery
Director, USC Institute of Orthopaedics, President of USC Care
Dr. Lieberman received his medical degree from the Albany Medical College of Union University and completed his fellowship training in total joint replacement at the Hospital for Special Surgery in New York.
He is a past president of the American Association of Hip and Knee Surgeons. He is a member of the Knee Society, the Hip Society and the International Hip Society. He is presently on the board of directors of the Hip Society. He has won numerous awards, including the Frank Stinchfield Hip Society Award; the Marshall Urist Award in recognition of his contributions to the field of tissue engineering; and the prestigious Elizabeth Winston Lanier Kappa Delta Award for his pioneering work related to the development of regional gene therapy to enhance bone repair.
Named an Outstanding Total Hip and Knee Orthopaedic Surgeon by Becker’s Spine Review, Dr. Lieberman was also named one of America’s Top Doctors in 2016 and 2017.
Dr. Lieberman’s clinical research aims to improve outcomes after total hip and knee replacement. He is interested in how pain management, aggressive physical therapy and preventing deep vein blood clots affect the results of total joint replacement surgery. He also has an interest in the influence of spirituality and mental health on the results of total joint replacement.